Pay in 4 interest-free payments of $6.07 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Pharmacologic Properties and Safety Drug Interactions and Side Effects Regulatory Approvals/Commercial Initially developed by Novo Nordisk, Liraglutide was approved by the US FDA in January 2010 with the commercial name Victoza
2010 Jan;49(1):61-75
***Based on a 6-month clinical trial (n=180) of individuals who were enrolled between FebruaryApril 2024, with overweight or obesity taking semaglutide or tirzepatide for weight loss and related outcomes through the WW Clinic Program and participating in the GLP-1 companion nutrition program
Related Reading Glp 1 For Losing Weight Zepbound For Losing Weight Ozempic For Losing Weight Mounjaro For Losing Weight Pricing and availability current as of June 2026
Oral delivery is not just convenient, its critical for the future of next-generation GLP-1 and similar therapeutic products
The fastest way is to change your diet
US$ 29.29
:max_bytes(150000):strip_icc()/Health-GettyImages-2190382211-1cdb5299c31943bd92857173e09da74e.jpg)
US$ 26.74
US$ 27.08
US$ 26.90
